Source: Atherosclerosis. Unidade: FM
Subjects: PREVENÇÃO DE DOENÇAS, DOENÇAS CARDIOVASCULARES, CUSTOS DOS CUIDADOS DE SAÚDE
ABNT
MORTON, Jedidiah I. et al. Lp(a) testing for the primary prevention of cardiovascular disease in high-income countries: a cost-effectiveness analysis. Atherosclerosis, v. 409, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/90787. Acesso em: 05 maio 2026.APA
Morton, J. I., Kronenberg, F., Daccord, M., Bedlington, N., Geanta, M., Silberzahn, T., et al. (2025). Lp(a) testing for the primary prevention of cardiovascular disease in high-income countries: a cost-effectiveness analysis. Atherosclerosis, 409. doi:10.1016/j.atherosclerosis.2025.120447NLM
Morton JI, Kronenberg F, Daccord M, Bedlington N, Geanta M, Silberzahn T, Chen Z, Eisele J-L, Eliasen B, Santos Filho RD dos. Lp(a) testing for the primary prevention of cardiovascular disease in high-income countries: a cost-effectiveness analysis [Internet]. Atherosclerosis. 2025 ; 409[citado 2026 maio 05 ] Available from: https://observatorio.fm.usp.br/handle/OPI/90787Vancouver
Morton JI, Kronenberg F, Daccord M, Bedlington N, Geanta M, Silberzahn T, Chen Z, Eisele J-L, Eliasen B, Santos Filho RD dos. Lp(a) testing for the primary prevention of cardiovascular disease in high-income countries: a cost-effectiveness analysis [Internet]. Atherosclerosis. 2025 ; 409[citado 2026 maio 05 ] Available from: https://observatorio.fm.usp.br/handle/OPI/90787
